2nd Health Equity and Outcomes Summit
Health Equity has become a growing issue of focus for pharmaceutical companies in recent years. With global events, including the COVID-19 pandemic; health inequities, especially within marginalized and underserved communities have been put under a microscope.
With a great push from both governmental and public entities, pharmaceutical companies have the daunting task of finding ways to be impactful socially through market access, health equity, and SDoH research, innovation, and development while still creating commercial value. While these companies have been making strides towards removing many barriers to health equity, there is still a long way to go.
This event will showcase how pharma companies collaborating with external and internal partners can truly close the gap on health equity and social disparities while also ensuring commercial success. Understanding that you can make an impact and still create an increase in fiscal achievement are key takeaways that can not be overlooked and should be at the forefront of your business models.